RESUMO
BACKGROUND: Psychological stress and heightened mast cell (MC) activation are linked with important immunologic disorders, including allergy, anaphylaxis, asthma, and functional bowel diseases, but the mechanisms remain poorly defined. We have previously demonstrated that activation of the corticotropin-releasing factor (CRF) system potentiates MC degranulation responses during IgE-mediated anaphylaxis and psychological stress through corticotropin-releasing factor receptor subtype 1 (CRF1) expressed on MCs. OBJECTIVE: In this study we investigated the role of corticotropin-releasing factor receptor subtype 2 (CRF2) as a modulator of stress-induced MC degranulation and associated disease pathophysiology. METHODS: In vitro MC degranulation assays were performed with bone marrow-derived mast cells (BMMCs) derived from wild-type (WT) and CRF2-deficient (CRF2-/-) mice and RBL-2H3 MCs transfected with CRF2-overexpressing plasmid or CRF2 small interfering RNA. In vivo MC responses and associated pathophysiology in IgE-mediated passive systemic anaphylaxis and acute psychological restraint stress were measured in WT, CRF2-/-, and MC-deficient KitW-sh/W-sh knock-in mice. RESULTS: Compared with WT mice, CRF2-/- mice exhibited greater serum histamine levels and exacerbated IgE-mediated anaphylaxis and colonic permeability. In addition, CRF2-/- mice exhibited increased serum histamine levels and colonic permeability after acute restraint stress. Experiments with BMMCs and RBL-2H3 MCs demonstrated that CRF2 expressed on MCs suppresses store-operated Ca2+ entry signaling and MC degranulation induced by diverse MC stimuli. Experiments with MC-deficient KitW-sh/W-sh mice systemically engrafted with WT and CRF2-/- BMMCs demonstrated the functional importance of MC CRF2 in modulating stress-induced pathophysiology. CONCLUSIONS: MC CRF2 is a negative global modulator of stimuli-induced MC degranulation and limits the severity of IgE-mediated anaphylaxis and stress-related disease pathogenesis.
Assuntos
Anafilaxia/imunologia , Mucosa Intestinal/metabolismo , Mastócitos/fisiologia , Receptores de Hormônio Liberador da Corticotropina/metabolismo , Estresse Psicológico/imunologia , Junções Íntimas/metabolismo , Animais , Degranulação Celular , Linhagem Celular , Modelos Animais de Doenças , Feminino , Liberação de Histamina/genética , Humanos , Imunoglobulina E/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Ratos , Receptores de Hormônio Liberador da Corticotropina/genéticaRESUMO
Intraperitoneal administration of the melanocortin agonist melanotan II (MTII) to mice causes a profound, transient hypometabolism/hypothermia. It is preserved in mice lacking any one of melanocortin receptors 1, 3, 4, or 5, suggesting a mechanism independent of the canonical melanocortin receptors. Here we show that MTII-induced hypothermia was abolished in KitW-sh/W-sh mice, which lack mast cells, demonstrating that mast cells are required. MRGPRB2 is a receptor that detects many cationic molecules and activates mast cells in an antigen-independent manner. In vitro, MTII stimulated mast cells by both MRGPRB2-dependent and -independent mechanisms, and MTII-induced hypothermia was intact in MRGPRB2-null mice. Confirming that MTII activated mast cells, MTII treatment increased plasma histamine levels in both wild-type and MRGPRB2-null, but not in KitW-sh/W-sh, mice. The released histamine produced hypothermia via histamine H1 receptors because either a selective antagonist, pyrilamine, or ablation of H1 receptors greatly diminished the hypothermia. Other drugs, including compound 48/80, a commonly used mast cell activator, also produced hypothermia by both mast cell-dependent and -independent mechanisms. These results suggest that mast cell activation should be considered when investigating the mechanism of drug-induced hypothermia in mice.
Assuntos
Agonistas dos Receptores Histamínicos/farmacologia , Hipotermia/induzido quimicamente , Mastócitos/efeitos dos fármacos , Peptídeos Cíclicos/farmacologia , alfa-MSH/análogos & derivados , Animais , Liberação de Histamina/efeitos dos fármacos , Liberação de Histamina/genética , Injeções Intraperitoneais , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , alfa-MSH/farmacologiaRESUMO
BACKGROUND: The microelectrode array (MEA) was used to investigate the pharmacological relevance of chloride (Cl-) ions in antigen-dependent mast cell activation and the inhibitory effect of disodium cromoglycate (DSCG) on mast cell activation. METHODS: The movements of ions across the cellular membrane and the potential relationship between Cl- channels and DSCG during immunological activation were investigated using the MEA. The results were then subsequently compared with the amount of histamine released from anti-IgE activated peritoneal mast cells. RESULTS: The inclusion of charybdotoxin (ChTX) in Cl--free buffer showed that the measured field potentials during antigen-stimulated peritoneal mast cell were a combination of Cl- influx and K+ efflux. The delayed onset time of Cl- influx indicated the presence of a delayed outwardly-rectifying Cl- current in the antigen-stimulated peritoneal mast cells. The use of 5-nitro-2-(3-phenylpropylamino) benzoic acid demonstrated that the activated mast cell membrane potential can be stabilised, thereby reducing the amount of histamine released from the anti-IgE activated mast cells. The correlation between the results of the histamine release assay and the electrophysiological measurements demonstrated the importance of Cl- to anti-IgE dependent mast cell activation. The inhibitory effect of DSCG on anti-IgE activated cells, however, did not correlate with the presumed influx of Cl-. CONCLUSIONS: The MEA data suggest that Cl- influx is crucial to IgE-dependent mast cell degranulation. GENERAL SIGNIFICANCE: While the MEA cannot yield information about single channel properties, it is convenient to use and can provide information on the global changes in electrophysiological responses of non-excitable cells.
Assuntos
Cloretos/farmacologia , Cromolina Sódica/farmacologia , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , Receptores de IgE/fisiologia , Animais , Anticorpos Anti-Idiotípicos/farmacologia , Charibdotoxina/farmacologia , Canais de Cloreto/efeitos dos fármacos , Canais de Cloreto/metabolismo , Liberação de Histamina/genética , Masculino , Microeletrodos , Nitrobenzoatos/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de IgE/efeitos dos fármacosRESUMO
In this study, we identify the bidirectional organic cation transporter 3 (OCT3/Slc22a3) as the molecule responsible for histamine uptake by murine basophils. We demonstrate that OCT3 participates in the control of basophil functions because exogenous histamine can inhibit its own synthesis--and that of interleukin (IL)-4, IL-6, and IL-13--through this means of transport. Furthermore, ligands of H3/H4 histamine receptors or OCT3 inhibit histamine uptake, and outward transport of newly synthesized histamine. By doing so, they increase the histamine content of basophils, which explains why they mimic the effect of exogenous histamine. These drugs were no longer effective in histamine-free histidine decarboxylase (HDC)-deficient mice, in contrast with histamine itself. Histamine was not taken up and lost its inhibitory effect in mice deficient for OCT3, which proved its specific involvement. Intracellular histamine levels were increased strongly in IL-3-induced OCT3-/- bone marrow basophils, and explained why they generated fewer cytokines than their wild-type counterpart. Their production was enhanced when histamine synthesis was blocked by the specific HDC inhibitor alpha-fluoro-methyl histidine, and underscored the determinant role of histamine in the inhibitory effect. We postulate that pharmacologic modulation of histamine transport might become instrumental in the control of basophil functions during allergic diseases.
Assuntos
Basófilos/metabolismo , Liberação de Histamina/fisiologia , Histamina/metabolismo , Histidina Descarboxilase/metabolismo , Proteínas de Transporte de Cátions Orgânicos/metabolismo , Animais , Basófilos/citologia , Transporte Biológico Ativo/genética , Transporte Biológico Ativo/fisiologia , Citocinas/metabolismo , Liberação de Histamina/genética , Histidina Descarboxilase/genética , Hipersensibilidade/genética , Hipersensibilidade/metabolismo , Camundongos , Camundongos Knockout , Proteínas de Transporte de Cátions Orgânicos/genética , Receptores Histamínicos H3/metabolismoRESUMO
BACKGROUND: Histamine plays an important role in allergic inflammation. Histamine levels are regulated by histamine N-methyltransferase (HNMT). OBJECTIVE: To investigate the functional variability of HNMT gene in relation to genetic polymorphisms in patients with aspirin intolerant chronic urticaria (AICU). METHODS: Two single-nucleotide polymorphisms of the HNMT gene (314C>T, 939A>G) were genotyped in chronic urticaria patients. The functional variability of 3'-untranslated region polymorphism (3'-UTR) was assessed using the pEGFP-HNMT 3'-UTR reporter construct to examine mRNA stability and fluorescence-tagged protein expression. The HNMT enzymatic activities related to the 939A>G polymorphism were examined both in the human mast cells (HMC-1) transfected with the pHNMT CDS-3'-UTR construct and in the patients' red blood cells (RBCs). Histamine release from the basophils of AICU patients was examined. RESULTS: The 939A>G polymorphism was significantly associated with the AICU phenotype, while no association was found with the 314C>T polymorphism. An in vitro functional study using HMC-1 cells demonstrated that the 939A allele gave lower levels of HNMT mRNA stability, HNMT protein expression, and HNMT enzymatic activity and higher histamine release than the 939G allele. The in vivo functional study demonstrated that the AICU patients with the 939A allele had lower HNMT activity in RBC lysates and higher histamine release from their basophils. CONCLUSION: The HNMT 939A>G polymorphism lowers HNMT enzymatic activity by decreasing HNMT mRNA stability, which leads to an increase in the histamine level and contributes to the development of AICU.
Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Aspirina/efeitos adversos , Histamina N-Metiltransferase/genética , Estabilidade de RNA/genética , Urticária/genética , Adulto , Alelos , Anti-Inflamatórios não Esteroides/imunologia , Aspirina/imunologia , Basófilos/imunologia , Basófilos/metabolismo , Estudos de Casos e Controles , Doença Crônica , Eritrócitos/imunologia , Eritrócitos/metabolismo , Feminino , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Histamina N-Metiltransferase/imunologia , Histamina N-Metiltransferase/metabolismo , Liberação de Histamina/genética , Liberação de Histamina/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Urticária/tratamento farmacológico , Urticária/imunologiaRESUMO
Asenapine is a novel psychopharmacologic agent under development for the treatment of schizophrenia and bipolar disorder. We determined and compared the human receptor binding affinities and functional characteristics of asenapine and several antipsychotic drugs. Compounds were tested under comparable assay conditions using cloned human receptors. In comparison with the antipsychotics, asenapine showed high affinity and a different rank order of binding affinities (pKi) for serotonin receptors (5-HT1A [8.6], 5-HT1B [8.4], 5-HT2A [10.2], 5-HT2B [9.8], 5-HT2C [10.5], 5-HT5 [8.8], 5-HT6 [9.6] and 5-HT7 [9.9]), adrenoceptors (alpha1 [8.9], alpha2A [8.9], alpha2B [9.5] and alpha2C [8.9]), dopamine receptors (D1 [8.9], D2 [8.9], D3 [9.4] and D4 [9.0]) and histamine receptors (H1 [9.0] and H2 [8.2]). It had much lower affinity (pKiAssuntos
Compostos Heterocíclicos de 4 ou mais Anéis/farmacologia
, Liberação de Histamina/efeitos dos fármacos
, Psicotrópicos/farmacologia
, Receptores Adrenérgicos/efeitos dos fármacos
, Receptores de Dopamina D2/efeitos dos fármacos
, Receptores Dopaminérgicos/efeitos dos fármacos
, Receptores Muscarínicos/efeitos dos fármacos
, Receptores de Serotonina/efeitos dos fármacos
, Benzodiazepinas/farmacologia
, Transtorno Bipolar/tratamento farmacológico
, Ensaios Clínicos como Assunto
, Clonagem Molecular
, Clozapina/farmacologia
, Dibenzocicloeptenos
, Compostos Heterocíclicos de 4 ou mais Anéis/química
, Compostos Heterocíclicos de 4 ou mais Anéis/uso terapêutico
, Liberação de Histamina/genética
, Humanos
, Concentração Inibidora 50
, Estrutura Molecular
, Olanzapina
, Psicotrópicos/química
, Psicotrópicos/uso terapêutico
, Ensaio Radioligante
, Receptores Adrenérgicos/genética
, Receptores Dopaminérgicos/genética
, Receptores de Dopamina D2/fisiologia
, Receptores Muscarínicos/genética
, Receptores de Serotonina/genética
, Esquizofrenia/tratamento farmacológico
, Especificidade por Substrato
RESUMO
BACKGROUND: Activation of mast cells (MCs) via aggregation of immunoglobulin E (IgE) bound to its high affinity receptor (FcepsilonRI) results in release of inflammatory mediators from secretory granules. Histamine is one of the critical biological mediators released in the allergic response. Synaptosomal-associated protein of 23 kDa (SNAP-23) and syntaxin 4 are plasma membrane proteins that have been associated with exocytosis in MCs. Studies with monoclonal IgEs indicate that binding of IgE to FcepsilonRI induces molecular and biological changes in OBJECTIVES: The aim of this study was to investigate changes in the expression of SNAP-23 and syntaxin 4 by MCs following rat sensitization with ovalbumin (OVA). In addition, we assessed whether these proteins were involved in histamine secretion. METHODS: SNAP-23 and syntaxin 4 expression was analyzed by Western blot using MCs from control and sensitized animals. Successful sensitization was confirmed based on the passive cutaneous anaphylaxis reaction. To test the role of these exocytotic proteins in histamine secretion, permeabilized MCs were incubated with SNAP-23 and syntaxin 4 antibodies. RESULTS: Expression of SNAP-23 and syntaxin 4 was significantly higher in MCs from OVA-sensitized rats than in cells from control animals. In addition, incubation of permabilized cells with antibodies to SNAP-23 and syntaxin 4 led to a marked reduction of histamine secretion in stimulated cells. CONCLUSIONS: Sensitization with OVA increases the expression of SNAP-23 and syntaxin 4 in MCs. Furthermore, our data suggest that these exocytotic proteins participate in histamine secretion.
Assuntos
Dessensibilização Imunológica , Exocitose/imunologia , Liberação de Histamina/imunologia , Mastócitos/metabolismo , Proteínas Qa-SNARE/imunologia , Proteínas Qa-SNARE/metabolismo , Proteínas Qb-SNARE/imunologia , Proteínas Qb-SNARE/metabolismo , Proteínas Qc-SNARE/imunologia , Proteínas Qc-SNARE/metabolismo , Animais , Permeabilidade Capilar/genética , Permeabilidade Capilar/imunologia , Células Cultivadas , Exocitose/genética , Regulação da Expressão Gênica , Liberação de Histamina/genética , Imunização , Masculino , Mastócitos/imunologia , Mastócitos/patologia , Ovalbumina/administração & dosagem , Anafilaxia Cutânea Passiva/genética , Anafilaxia Cutânea Passiva/imunologia , Proteínas Qa-SNARE/genética , Proteínas Qb-SNARE/genética , Proteínas Qc-SNARE/genética , Ratos , Ratos WistarRESUMO
Gastric enterochromaffin-like (ECL) cells release histamine in response to food because of elevation of gastrin and neural release of pituitary adenylate cyclase-activating peptide (PACAP). Acid secretion is at a basal level in the absence of food but is rapidly stimulated with feeding. Rats fasted for 24 h showed a significant decrease of mucosal histamine despite steady-state expression of the histamine-synthesizing enzyme histidine decarboxylase (HDC). Comparative transcriptomal analysis using gene expression oligonucleotide microarrays of 95% pure ECL cells from fed and 24-h fasted rats, thereby eliminating mRNA contamination from other gastric mucosal cell types, identified significantly increased gene expression of the enzymes histidase and urocanase catabolizing the HDC substrate L-histidine but significantly decreased expression of the cellular L-histidine uptake transporter SN2 and of the vesicular monoamine transporter 2 (VMAT-2) responsible for histamine uptake into secretory vesicles. This was confirmed by reverse transcriptase-quantitative polymerase chain reaction of gastric fundic mucosal samples from fed and 24-h fasted rats. The decrease of VMAT-2 gene expression was also shown by a decrease in VMAT-2 protein content in protein extracts from fed and 24-h fasted rats compared with equal amounts of HDC protein and Na-K-ATPase alpha(1)-subunit protein content. These results indicate that rat gastric ECL cells regulate their histamine content during 24-h fasting not by a change in HDC gene or protein expression but by regulation of substrate concentration for HDC and a decreased histamine secretory pool.
Assuntos
Células Enterocromafins/metabolismo , Jejum/metabolismo , Regulação da Expressão Gênica/fisiologia , Liberação de Histamina/genética , Sistemas de Transporte de Aminoácidos Neutros/biossíntese , Sistemas de Transporte de Aminoácidos Neutros/genética , Animais , Contagem de Células , Indução Enzimática , Perfilação da Expressão Gênica , Histamina/metabolismo , Liberação de Histamina/fisiologia , Histidina Amônia-Liase/biossíntese , Histidina Amônia-Liase/genética , Histidina Descarboxilase/metabolismo , Masculino , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , ATPase Trocadora de Sódio-Potássio/biossíntese , ATPase Trocadora de Sódio-Potássio/genética , Transcrição Gênica , Urocanato Hidratase/biossíntese , Urocanato Hidratase/genética , Proteínas Vesiculares de Transporte de Monoamina/biossíntese , Proteínas Vesiculares de Transporte de Monoamina/genéticaRESUMO
Adapter molecule Grb2-associated binder-like protein 2 (Gab2) plays a critical role in FcepsilonRI-induced mast cell degranulation and activation. The present study aimed to investigate the pharmacological effects of an antisense oligonucleotide (ASO) targeted at Gab2 on the immune responses of rat basophilic leukemic (RBL)-2H3 cells. Gab2 ASOs were rationally designed and transfected into RBL-2H3 cells. Gab2 mRNA and protein knockdown was confirmed by real-time RT-PCR and immunoblotting, respectively. Effects of Gab2 ASO on FcepsilonRI-induced release of histamine and beta-hexosaminidase was measured by EIA and an enzymatic assay, respectively; signaling events by immunoblotting; and cytokine mRNA expression by RT-PCR. Effects of Gab2 ASO on cell adhesion and migration were performed on fibronectin-coated 96-well plate and transwells cell culture chambers, respectively. We have characterized a phosphorothioate-modified ASO targeted at Gab2 mRNA that was able to knockdown Gab2 mRNA and protein in RBL-2H3 cells. Gab2 ASO significantly blocked IgE-mediated mast cell release of beta-hexosaminidase and histamine; phosphorylation of Akt, p38 mitogen-activated protein kinase and PKCdelta; and up-regulation of cytokine mRNA levels (e.g. IL-4, -6, -9 and -13, and TNF-alpha). In addition, Gab2 ASO markedly prevented mast cell adhesion to fibronectin-coated plates and restrained random migration of RBL-2H3 cells in cell culture chambers. Our findings show that Gab2 knockdown in RBL-2H3 cells by ASO strategy can suppress many aspects of the mast cell functions and, therefore, a selective Gab2 ASO may have therapeutic potential for mast cell-dependent allergic disorders.
Assuntos
Basófilos/imunologia , Leucemia Basofílica Aguda/tratamento farmacológico , Leucemia Basofílica Aguda/imunologia , Oligonucleotídeos Antissenso/farmacologia , Fosfoproteínas/genética , RNA Mensageiro/metabolismo , Transdução de Sinais/genética , Proteínas Adaptadoras de Transdução de Sinal , Animais , Adesão Celular/genética , Movimento Celular/genética , Citocinas/genética , Citocinas/metabolismo , Fibronectinas/metabolismo , Marcação de Genes , Liberação de Histamina/genética , Liberação de Histamina/imunologia , Mastócitos/imunologia , Fosfoproteínas/biossíntese , Fosfoproteínas/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Ratos , Receptores de IgE/antagonistas & inibidores , Receptores de IgE/genética , Células Tumorais Cultivadas , beta-N-Acetil-Hexosaminidases/imunologiaRESUMO
OBJECTIVE: Food additives can exacerbate ADHD symptoms and cause non-immunoglobulin E-dependent histamine release from circulating basophils. However, children vary in the extent to which their ADHD symptoms are exacerbated by the ingestion of food additives. The authors hypothesized that genetic polymorphisms affecting histamine degradation would explain the diversity of responses to additives. METHOD: In a double-blind, placebo-controlled crossover trial, challenges involving two food color additive and sodium benzoate (preservative) mixtures in a fruit drink were administered to a general community sample of 3-year-old children (N = 153) and 8/9-year-old children (N = 144). An aggregate ADHD symptom measure (based on teacher and parent blind ratings of behavior, blind direct observation of behavior in the classroom, and--for 8/9-year-old children only--a computerized measure of attention) was the main outcome variable. RESULTS: The adverse effect of food additives on ADHD symptoms was moderated by histamine degradation gene polymorphisms HNMT T939C and HNMT Thr105Ile in 3- and 8/9-year-old children and by a DAT1 polymorphism (short versus long) in 8/9-year-old children only. There was no evidence that polymorphisms in catecholamine genes COMT Val108Met, ADRA2A C1291G, and DRD4-rs7403703 moderated the effect on ADHD symptoms. CONCLUSIONS: Histamine may mediate the effects of food additives on ADHD symptoms, and variations in genes influencing the action of histamine may explain the inconsistency between previous studies. Genes influencing a range of neurotransmitter systems and their interplay with environmental factors, such as diet, need to be examined to understand genetic influences on ADHD symptoms.
Assuntos
Transtorno do Deficit de Atenção com Hiperatividade/induzido quimicamente , Transtorno do Deficit de Atenção com Hiperatividade/genética , Aditivos Alimentares/efeitos adversos , Histamina/genética , Polimorfismo de Nucleotídeo Único/genética , Adolescente , Transtorno do Deficit de Atenção com Hiperatividade/diagnóstico , Criança , Dieta/efeitos adversos , Dopamina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Dopamina/genética , Feminino , Aditivos Alimentares/farmacologia , Corantes de Alimentos/efeitos adversos , Corantes de Alimentos/farmacologia , Histamina/metabolismo , Histamina N-Metiltransferase/genética , Liberação de Histamina/efeitos dos fármacos , Liberação de Histamina/genética , Humanos , Desequilíbrio de Ligação , Masculino , Receptores de Dopamina D4/efeitos dos fármacos , Receptores de Dopamina D4/genéticaAssuntos
Urticária/imunologia , Autoanticorpos/imunologia , Doenças Autoimunes/classificação , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/epidemiologia , Doenças Autoimunes/genética , Doenças Autoimunes/imunologia , Doença Crônica , Complemento C5a/imunologia , Antígenos HLA-DQ/genética , Antígenos HLA-DQ/imunologia , Cadeias beta de HLA-DQ , Antígenos HLA-DR/genética , Antígenos HLA-DR/imunologia , Cadeias HLA-DRB1 , Liberação de Histamina/genética , Liberação de Histamina/imunologia , Humanos , Programas de Rastreamento/métodos , Mastócitos/imunologia , Linhagem , Prevalência , Receptores de IgE/imunologia , Urticária/classificação , Urticária/diagnóstico , Urticária/epidemiologia , Urticária/genéticaRESUMO
FcepsilonRI, The high affinity receptor for IgE plays a critical role in triggering the allergic reactions. It is responsible for inducing mast cell degranulation and deliberation of allergy mediators when it is aggregated by allergen and IgE complexes. FcepsilonRI on the mast cells consists of three subunits; alpha chain directly binds IgE, beta chain and dimmer of gamma chains together mediate intracellular signaling. Cross-linking of IgE-bound FcepsilonRI on the surface of mast cells and basophils by the multivalent antigen induces release of chemical mediators. The present in vitro study was designed to investigate the effect of synthetic FcepsilonRI-alpha siRNA on the antigen-induced activation of MC/9 cells. MC/9 cells which are murine mast cells were transfected by FcepsilonRI-alpha siRNA and negative control siRNA. After 6 h, anti-DNP (Dinitrophenyl) IgE was used for the cells sensitization. Then the cells were challenged with Dinitrophenyl-Human Serum Albumin (DNP-HSA) for mast cell degranulation induction before collection of supernatants. The amount of mRNA and protein expression was measured by Real Time PCR and western blot analysis, respectively. Determination of the expression rate of FcepsilonRI-alpha on cell surface was achieved by flow cytometry. ELISA and spectrophotometry methods were used subsequently for measuring the effects of FcepsilonRI-alpha siRNA on antigen-induced histamine and beta-hexosaminidase release. FcepsilonRI-alpha siRNA treated cells showed significant decrease in FcepsilonRI-alpha mRNA and protein expression in comparison to control cells. FcepsilonRI-mediated mast cell release of beta-hexosaminidase and histamine were also inhibited. In this study it was shown that FcepsilonRI-alpha siRNA could suppress FcepsilonRI-alpha expression and inhibited degranulation and histamine release in antigen-stimulated MC/9 cells. In conclusion, knock-down of FcepsilonRI-alpha by siRNA could be a promising method for inhibition of the mast cell-mediated allergic reactions.
Assuntos
Antígenos/imunologia , Degranulação Celular/imunologia , Imunoglobulina E/imunologia , Mastócitos/imunologia , RNA Interferente Pequeno/imunologia , Receptores de IgE/imunologia , Transdução de Sinais/imunologia , Alérgenos/imunologia , Alérgenos/metabolismo , Animais , Antígenos/metabolismo , Antígenos/farmacologia , Asma/genética , Asma/imunologia , Asma/metabolismo , Asma/terapia , Basófilos/imunologia , Basófilos/metabolismo , Degranulação Celular/efeitos dos fármacos , Degranulação Celular/genética , Linhagem Celular , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Regulação da Expressão Gênica/imunologia , Histamina/imunologia , Histamina/metabolismo , Liberação de Histamina/efeitos dos fármacos , Liberação de Histamina/genética , Liberação de Histamina/imunologia , Humanos , Imunoglobulina E/metabolismo , Imunoglobulina E/farmacologia , Capeamento Imunológico , Mastócitos/metabolismo , Camundongos , RNA Interferente Pequeno/biossíntese , RNA Interferente Pequeno/genética , Receptores de IgE/antagonistas & inibidores , Receptores de IgE/biossíntese , Receptores de IgE/genética , Transdução de Sinais/genéticaRESUMO
We previously showed that transgenic enhancement of histamine production in B16-F10 melanomas strongly supports tumor growth in C57BL/6 mice. In the present study, gene expression profiles of transgenic mouse melanomas, secreting different amounts of histamine, were compared by whole genome microarrays. Array results were validated by real-time PCR, and genes showing histamine-affected behavior were further analyzed by immunohistochemistry. Regulation of histamine-coupled genes was investigated by checking the presence and functional integrity of all four known histamine receptors in experimental melanomas and by administering histamine H1 receptor (H1R) and H2 receptor (H2R) antagonists to tumor-bearing mice. Finally, an attempt was made to integrate histamine-affected genes in known gene regulatory circuits by in silico pathway analysis. Our results show that histamine enhances melanoma growth via H1R rather than through H2R. We show that H1R activation suppresses RNA-level expression of the tumor suppressor insulin-like growth factor II receptor (IGF-IIR) and the antiangiogenic matrix protein fibulin-5 (FBLN5), decreases their intracellular protein levels, and also reduces their availability in the plasma membrane and extracellular matrix, respectively. Pathway analysis suggests that because plasma membrane-bound IGF-IIR is required to activate matrix-bound, latent transforming growth factor-beta1, a factor suggested to sustain FBLN5 expression, the data can be integrated in a known antineoplastic regulatory pathway that is suppressed by H1R. On the other hand, we show that engagement of H2R also reduces intracellular protein pools of IGF-IIR and FBLN5, but being a downstream acting posttranslational effect with minimal consequences on exported IGF-IIR and FBLN5 protein levels, H2R is rather irrelevant compared with H1R in melanoma.
Assuntos
Proteínas da Matriz Extracelular/biossíntese , Liberação de Histamina/fisiologia , Melanoma Experimental/metabolismo , Receptor IGF Tipo 2/biossíntese , Proteínas Recombinantes/biossíntese , Animais , Western Blotting , Proteínas da Matriz Extracelular/antagonistas & inibidores , Proteínas da Matriz Extracelular/genética , Feminino , Perfilação da Expressão Gênica , Histamina/biossíntese , Histamina/genética , Antagonistas dos Receptores Histamínicos/farmacologia , Liberação de Histamina/genética , Imuno-Histoquímica , Melanoma Experimental/genética , Melanoma Experimental/patologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Família Multigênica , Análise de Sequência com Séries de Oligonucleotídeos , Receptor IGF Tipo 2/antagonistas & inibidores , Receptor IGF Tipo 2/genética , Receptores Histamínicos/fisiologia , Proteínas Recombinantes/antagonistas & inibidores , Proteínas Recombinantes/genéticaRESUMO
The Tec family tyrosine kinase, IL-2-inducible T cell kinase (Itk), is expressed in T cells and mast cells. Mice lacking Itk exhibit impaired Th2 cytokine secretion; however, they have increased circulating serum IgE, but exhibit few immunological symptoms of allergic airway responses. We have examined the role of Itk in mast cell function and FcepsilonRI signaling. We report in this study that Itk null mice have reduced allergen/IgE-induced histamine release, as well as early airway hyperresponsiveness in vivo. This is due to the increased levels of IgE in the serum of these mice, because the transfer of Itk null bone marrow-derived cultured mast cells into mast cell-deficient W/W(v) animals is able to fully rescue histamine release in the W/W(v) mice. Further analysis of Itk null bone marrow-derived cultured mast cells in vitro revealed that whereas they have normal degranulation responses, they secrete elevated levels of cytokines, including IL-13 and TNF-alpha, particularly in response to unliganded IgE. Analysis of biochemical events downstream of the FcepsilonRI revealed little difference in overall tyrosine phosphorylation of specific substrates or calcium responses; however, these cells express elevated levels of NFAT, which was largely nuclear. Our results suggest that the reduced mast cell response in vivo in Itk null mice is due to elevated levels of IgE in these mice. Our results also suggest that Itk differentially modulates mast cell degranulation and cytokine production in part by regulating expression and activation of NFAT proteins in these cells.
Assuntos
Mastócitos/enzimologia , Mastócitos/imunologia , Proteínas Tirosina Quinases/fisiologia , Alérgenos/administração & dosagem , Animais , Transplante de Medula Óssea/imunologia , Hiper-Reatividade Brônquica/enzimologia , Hiper-Reatividade Brônquica/genética , Hiper-Reatividade Brônquica/imunologia , Hiper-Reatividade Brônquica/prevenção & controle , Degranulação Celular/genética , Degranulação Celular/imunologia , Células Cultivadas , Citocinas/metabolismo , Dinitrobenzenos/imunologia , Modelos Animais de Doenças , Liberação de Histamina/genética , Liberação de Histamina/imunologia , Imunoglobulina E/administração & dosagem , Imunoglobulina E/biossíntese , Imunoglobulina E/metabolismo , Mastócitos/metabolismo , Camundongos , Camundongos Congênicos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas Tirosina Quinases/deficiência , Proteínas Tirosina Quinases/genética , Receptores de IgE/metabolismo , Receptores de IgE/fisiologia , Transdução de Sinais/genética , Transdução de Sinais/imunologiaRESUMO
Most human blood basophils respond to FcepsilonRI cross-linking by releasing histamine and other inflammatory mediators. Basophils that do not degranulate after anti-IgE challenge, known as "nonreleaser" basophils, characteristically have no or barely detectable levels of the Syk tyrosine kinase. The true incidence of the nonreleaser phenotype, its relationship (if any) to allergic asthma, and its molecular mechanism are not well understood. In this study, we report statistical analyses of degranulation assays performed in 68 control and 61 asthmatic subjects that establish higher basal and anti-IgE-stimulated basophil degranulation among the asthmatics. Remarkably, 28% of the control group and 13% of the asthmatic group were nonreleasers for all or part of our 4-year long study and cycling between the releaser and nonreleaser phenotypes occurred at least once in blood basophils from 8 (of 8) asthmatic and 16 (of 23) control donors. Microarray analysis showed that basal gene expression was generally lower in nonreleaser than releaser basophils. In releaser cells, FcepsilonRI cross-linking up-regulated >200 genes, including genes encoding receptors (the FcepsilonRI alpha and beta subunits, the histamine 4 receptor, the chemokine (C-C motif) receptor 1), signaling proteins (Lyn), chemokines (IL-8, RANTES, MIP-1alpha, and MIP-1beta) and transcription factors (early growth response-1, early growth response-3, and AP-1). FcepsilonRI cross-linking induced fewer, and quite distinct, transcriptional responses in nonreleaser cells. We conclude that "nonreleaser" and "cycler" basophils represent a distinct and reversible natural phenotype. Although histamine is more readily released from basophils isolated from asthmatics than controls, the presence of nonreleaser basophils does not rule out the diagnosis of asthma.
Assuntos
Asma/imunologia , Basófilos/imunologia , Expressão Gênica , Liberação de Histamina/genética , Adolescente , Adulto , Anticorpos Anti-Idiotípicos/farmacologia , Antígenos CD/efeitos dos fármacos , Asma/genética , Feminino , Perfilação da Expressão Gênica , Liberação de Histamina/efeitos dos fármacos , Humanos , Imunoglobulina E/imunologia , Masculino , Análise de Sequência com Séries de Oligonucleotídeos , Receptores Fc/efeitos dos fármacos , Transcrição Gênica , Regulação para CimaRESUMO
The pathogenic mechanism of ASA-induced urticaria/angioedema (AIU) is still poorly understood, but it has been known that histamine releasing by cutaneous mast cell activation is considered to be an important role. Considering the importance of histamine in AIU, we speculated that a genetic abnormality of histamine-related genes such as a high-affinity IgE receptor, a metabolic enzyme of histamines and histamine receptors, may be involved in the development of AIU. Enrolled in the study were 110 patients with AIU, 53 patients without ASA hypersensitivity who had various drug allergies presenting as exanthematous skin symptoms, and 99 normal healthy controls (NC). Eleven single nucleotide polymorphisms (SNPs) of the beta chain of the high-affinity IgE receptor (FCER1B) and three histamine-related genes-histamine N-methyltransferase (HNMT), histamine H1 receptor (HRH1), histamine H2 receptor (HRH2)-were screened using the SNP-IT assay based on a single base extension method. No significant differences were observed in allele and genotype frequencies, and haplotype frequencies of all the SNPs of FCER1B, HNMT, HRH1, and HRH2 among the three groups (p>0.05, respectively). These results suggest that the polymorphisms of FCER1B and the three histamine-related genes may not contribute to the development of AIU phenotype in the Korean population.
Assuntos
Angioedema/genética , Histamina/metabolismo , Polimorfismo de Nucleotídeo Único , Receptores de IgE/genética , Urticária/genética , Adulto , Alelos , Angioedema/induzido quimicamente , Angioedema/metabolismo , Aspirina , Feminino , Frequência do Gene , Genótipo , Haplótipos , Liberação de Histamina/genética , Humanos , Desequilíbrio de Ligação , Masculino , Pessoa de Meia-Idade , Urticária/induzido quimicamente , Urticária/metabolismoRESUMO
The relationship between the IgE load on mast cells and their secretory capacity when challenged with anti-IgE was studied in peritoneal cells obtained from rats of three different strains, Hooded Lister (HL), Wistar Kyoto (WKY) and Sprague-Dawley (SD). IgE was determined cytofluorometrically after labelling with FITC-conjugated anti-IgE before and after the saturation of the IgE receptors to provide a measure of the surface expression of IgE receptors (number of receptors available for bindings) as well as the IgE occupancy of the receptors (native IgE content). The secretory capacity of the mast cells was examined in vitro in terms of histamine release as a function of anti-IgE concentration. Mast cells obtained from HL and WKY rats were found to carry significantly higher levels of IgE receptors and IgE than the mast cells of SD rats bred and raised under the same conventional laboratory conditions. The mast cells of SD rats kept under barrier-maintained conditions carried significantly less IgE than the mast cells obtained from SD rats kept under conventional conditions, but their IgE receptor levels were similar. The IgE-mediated histamine-releasing capacity of the mast cells, evaluated in terms of maximum release or of the slopes of regression lines (histamine release versus anti-IgE concentration), was positively correlated to the levels of native IgE and IgE receptors in the three strains of rat combined. The mast cells obtained from WKY rats showed the highest secretory capacity in the three strains of rat examined, significantly higher than the mast cells of HL rats, even though the latter displayed similar levels of IgE and IgE receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Liberação de Histamina/genética , Imunoglobulina E/imunologia , Mastócitos/imunologia , Receptores de IgE/biossíntese , Animais , Imunoglobulina E/genética , Masculino , Mastócitos/ultraestrutura , Ratos , Ratos Endogâmicos , Ratos Endogâmicos WKY , Ratos Sprague-Dawley , Receptores de IgE/genética , Especificidade da Espécie , Organismos Livres de Patógenos Específicos/imunologiaRESUMO
IgE receptor density and IgE occupancy were quantified on individual peritoneal mast cells using cytofluorometry. The secretory capacity of the mast cells was analysed in terms of histamine release as a function of anti-IgE challenge. Histamine releasability was found to be largely a function of the number of IgE molecules on the mast cells. The genetic background influenced IgE receptor expression but also, independently, histamine releasability. Both IgE receptor density and IgE occupancy on the mast cells appeared to be T cell independent under normal conditions. Up-regulated IgE receptor expression and an increased IgE occupancy on the mast cells could be obtained in athymic rats in response to a Nippostrongylus brasiliensis infection, although it was not as pronounced as in euthymic rats. The secretory response was diminished in athymic rats, suggesting that T cell factor(s) enhance secretory signal transduction in the mast cells in vivo.
Assuntos
Liberação de Histamina , Imunoglobulina E/metabolismo , Mastócitos/metabolismo , Receptores de IgE/metabolismo , Linfócitos T/imunologia , Animais , Liberação de Histamina/genética , Masculino , Nippostrongylus , Ratos , Ratos Endogâmicos Lew , Ratos Endogâmicos , Ratos Endogâmicos WKY , Ratos Nus , Ratos Sprague-Dawley , Transdução de Sinais , Organismos Livres de Patógenos Específicos , Infecções por Strongylida/imunologia , Regulação para CimaRESUMO
The homologous venom allergen Ag 5s from the yellow jacket (Vespula vulgaris) and paper wasp (Polistes annularis) have 59% sequence identity of their respective 204 and 205 amino acid residues, and they have low degrees of antigenic cross-reactivity in insect allergic patients and in animal models. Hybrids containing different segments of these two vespid Ag 5s were expressed in yeast. Circular dichroism spectroscopy suggests the hybrids to have the secondary structure of natural Ag 5. Inhibition ELISA with human and murine Abs suggests the hybrids to have the discontinuous B cell epitopes of the natural Ag 5 but with an altered epitope density. The hybrids were immunogenic in mice for B and T cell responses to both Ag 5s. The N-terminal region of Ag 5 was found to contain its dominant B cell epitope(s). Hybrids containing 10-49 residues of yellow jacket Ag 5 showed 100- to 3000-fold reduction in allergenicity when tested by histamine release assay with basophils of yellow jacket-sensitive patients. Our findings suggest that hybrids represent a useful approach to map the discontinuous B cell epitope-containing regions of proteins. They also suggest that Ag 5 hybrids may be useful immunotherapeutic reagents in man.
Assuntos
Alérgenos/genética , Alérgenos/imunologia , Proteínas Recombinantes de Fusão/imunologia , Venenos de Vespas/genética , Venenos de Vespas/imunologia , Alérgenos/química , Sequência de Aminoácidos , Animais , Sequência de Bases , Dicroísmo Circular , Relação Dose-Resposta Imunológica , Eletroforese em Gel de Poliacrilamida , Epitopos de Linfócito B/genética , Epitopos de Linfócito B/imunologia , Feminino , Vetores Genéticos/imunologia , Liberação de Histamina/genética , Liberação de Histamina/imunologia , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Pichia/genética , Pichia/imunologia , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/síntese química , Homologia de Sequência de Aminoácidos , Venenos de Vespas/síntese químicaRESUMO
An important approach to understanding complex diseases is to reduce them into well-characterized subphenotypes that are under monogenic control. One such example is Bordetella pertussis toxin-induced histamine sensitization in mice, a subphenotype of experimental allergic encephalomyelitis and experimental allergic orchitis. This subphenotype is controlled by a single locus, Bphs, previously mapped to a 33 cM region on mouse Chromosome (Chr) 6. We achieved considerable reduction of this candidate region and constructed a YAC contig across the refined interval. Our results demonstrate that Bphs is located between D6Mit151 and a newly developed marker, EC108RR, a region containing a small cluster of genes belonging to the TNF receptor superfamily. Sequence and quantitative analysis of the candidate gene, tumor necrosis factor receptor 1 (Tnfr1, p55), indicates that it is unlikely to be Bphs. However, the location of Bphs, together with physiologic effects it shares with Tnfr1 activation, suggest that Bphs may prove to be another member of the TNF receptor superfamily.